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The Postural Assessment Scale for Stroke Patients: Translation into 
Norwegian, cultural adaptation and examination of reliability  
Abstract 
Background: To translate the Modified Swedish version of Postural Assessment Scale for Stroke 
(SwePASS) into Norwegian (SwePASS-NV) and assess its intra- and interrater reliability. Methods: 
Translation and cross-cultural adaptation was accomplished according to international guidelines. 
Forty-seven adults, suffering a stroke within the last six months, were strategically recruited and 
allocated into groups according to five different levels of function. Their performance on SwePASS-
NV was video-recorded and then scored by three raters twice, with a minimum of 4 weeks between 
sessions. Relative reliability was investigated by calculating intraclass correlation coefficients (ICC1.1 
and ICC3.1). Absolute reliability was analysed using within-subject standard deviation (Sw) and 
smallest detectable difference (SDD). For individual items, Cohen’s kappa (k) and percentage of 
agreement were calculated. Results: The study showed excellent intra- and interrater reliability (ICC1.1 
and ICC3.1 ≥.99) for SwePASS-NV. K-values for the individual items ranged between 0.68–1.00. 
Percentages of agreement ranged from 77-100%. SDD at 95% confidence interval was ≤ 2 points for 
intrarater assessments and ≤ 3 points for interrater assessments. Conclusion: This study demonstrated 
very high intra- and interrater reliability of the SwePASS-NV in adults within the first six months after 
stroke. All items showed very high or high agreement. 
 











Stroke is the third leading cause of death and a major cause of lasting disability among the 
elderly, and in Norway approximately 15,000 persons suffer a stroke each year (1). This 
number is expected to rise due to a presumed increase in the number of older people in the 
decades to come (2). Impaired balance is a common problem amongst these patients, affecting 
up to 80% in the initial stages (3). Reduced balance can severely influence the patient’s ability 
to perform activities of daily living and is associated with reduced quality of life (4). There is 
a need for reliable measurements designed to evaluate and monitor balance in the initial phase 
after stroke and throughout the rehabilitation process (5, 6). Good measurements of balance 
may predict later disability, assist in selecting the most appropriate therapy, and assess 
changes (7). Several different tests exist but there is no consensus on a ‘gold standard' (8). 
Many of the tests used today are not optimal for patients with poor balance, due to a floor 
effect (9, 10).  
The Postural Assessment Scale for Stroke Patients (PASS) was developed specifically 
to evaluate balance after stroke and is applicable for all including those with poor postural 
control (9). It has shown high intrarater and interrater reliability (9), good individual item 
agreement (11), and acceptable or high test-retest reliability (7, 12). PASS has been examined 
for different aspects of validity in several studies, showing good to excellent validity (9, 11, 
13-15). Clinical instruments should be used in the patient’s native language to ensure a 
common understanding of the original intention with the test. PASS has previously been 
translated into English, Swedish, Portuguese and Spanish (9, 16-18). The Swedish version of 
PASS, SwePASS, is a new and modified version of the test (16). The aim of the present study 
was to translate the SwePASS into Norwegian and to examine its intrarater and interrater 
reliability in the acute and sub-acute phases after stroke.  
Methods 
Design  
The present study was conducted in two stages. First, the English back-translation of 
SwePASS, the SwePASS-EV, was translated into Norwegian, SwePASS-NV, and cross-
culturally adapted according to international guidelines. Second, a methodological study of 
intrarater and interrater reliability of SwePASS-NV was performed. The participants’ 





and interrater reliability. The Norwegian Social Science Data Services and the data 
protection officer at HUH approved the study. The participants gave their written 
informed consent. If the participant was not able to understand the information, the 
next of kin gave informed consent. 
Setting 
The study was conducted from October 2013 to December 2014 at the Department of 
Physical Medicine and Rehabilitation (DPMR) and the Department of Neurology at 
Haukeland University Hospital (HUH), Bergen, Norway.  
PASS and SwePASS 
PASS is used to assess the ability to maintain or change positions in lying, sitting and 
standing, and contains items with varying degrees of difficulty (9). PASS consists of twelve 
items (scoring 0-3, 3=highest/best) with a maximum total score of 36 points. The SwePASS 
modifications include a change in the order of the items, which in the SwePASS are listed in 
the same order as they are logically performed in a clinical situation. Moreover, in item 10 of 
PASS the participant is asked to pick up an object/pencil, which in SwePASS is changed to a 
shoe/slipper, to minimise a possible impact of fine motor skills. In addition, the scoring 
criteria have been clarified, where ‘much help' is defined as ‘support of two persons' and 'little 
help' as 'support of one person'. These modifications and clarifications are in accordance with 
our clinical experience and in line with a previous study (19). 
Translation and cross-cultural adaptation 
SwePASS-EV was translated into Norwegian following international guidelines (20) after 
consent from the developers of PASS (9) and SwePASS (16). Two physiotherapists and a 
speech therapist, all bi-lingual (Norwegian/English), translated SwePASS-EV into 
Norwegian separately. The three versions were compared and consensus reached for a first 
draft. In a pilot study including five stroke patients, the test was tried out clinically. The first 
draft together with the experiences and questions from the pilot study were discussed by an 
expert panel consisting of the forward translators and the first (KB) and second (BEBG) 
authors. Consensus was reached for a second draft of SwePASS-NV. A bi-lingual 





translated the second version back into English.  
Reliability study 
Study sample 
Acute and sub-acute patients with stroke were recruited by physiotherapists working at the 
two departments. Inclusion criteria: diagnosed with stroke and ≥ 18 years of age. Stroke was 
defined according to the World Health Organisation criteria (21), and the diagnosis confirmed 
with MRI or CT. Individuals that could not follow test instructions or had impaired balance 
due to other diagnoses were not included. In order to enable evaluation of the whole range of 
scores of the SwePASS-NV, the participants were strategically selected based on their level of 
function and allocated to the following groups by their treating physiotherapist: 
Group 1 Cannot sit without support. 
Group 2 Can sit without support for 10 seconds; need much support/help of two persons 
when transferring. 
Group 3 Can sit without support for more than 10 seconds; need only slight 
support/supervision with transfers. 
Group 4 Can transfer independently, in a secure manner. 
Group 5 Can stand on the affected leg without support or walk independently without a 
walking aid. 
Age, sex and information about the stroke (date of incident, type of stroke, brain localisation 
and most affected body half) were registered for all participants.  
Testing procedures 
A research assistant video-recorded the participants during their performance of SwePASS-
NV in accordance with a pre-standardised procedure. The testers were all physiotherapists 
who worked at the two recruiting departments. Their experience with neurological patients 
and with PASS/SwePASS varied from none to extensive. To ensure that they all had a basic 
degree of common understanding, they were given an hour training session by the first author 
before testing commenced. 
At the respective departments, the same rooms were used during testing. The angle 





stopwatch) were standardised. Testing was conducted in accordance with a manual developed 
for the SwePASS-NV and the items were performed in the same order each time. If two 
persons were needed to assist the participant, the research assistant would help. The 
participants had the opportunity to take breaks if necessary. Time taken to complete the test 
varied from eight to fifteen minutes.  
Raters and rating procedure 
Three physiotherapists who were not involved in the testing, rated the participants’ 
performance on SwePASS-NV based on the video recordings, which were not edited in any 
way. These raters, labelled A, B and C, were selected among the staff working with stroke 
patients at DPMR. Raters A and B had 12 and 10 years clinical experience, respectively, and 
mostly with neurological patients. They had previous experience with the PASS from clinical 
work and other studies. Rater C was a junior physiotherapist with no experience with 
neurorehabilitation or PASS or SwePASS.  
Prior to the main study, the raters participated in two one-hour training sessions to 
become familiar with the test and scoring instructions, and create a common understanding. 
This was achieved by rating five stroke patients (those included in the pilot study) on their 
performance of SwePASS-NV. The recordings were scored individually and then discussed 
between them.  
The three raters scored the video recordings of the participants twice, with a minimum 
of four weeks between the first (A1, B1, C1) and second (A2, B2, C2) rating. The raters used 
a stopwatch each when scoring items 7, 8 and 9. Each rater assigned scores independently, 
and was instructed not to discuss the scores with each other during or between the two ratings. 
The order of the video recordings differed between the two ratings. With the intention to 
make the rating as similar as possible to direct scoring in the clinic, the raters watched the 
video recordings once and scored during the viewing. A fresh SwePASS-NV assessment form 
was distributed for each participant and the forms were unavailable for the raters after the 
assessment was completed. The raters were not informed about the participants’ group 
allocation. 
Data analysis 





for continuous variables or percentages for dichotomous variables. The correlation between 
the total score on SwePASS-NV (mean value of all six ratings) and the group allocation was 
examined using Spearman’s rho statistics.  
Intraclass correlation coefficients (ICC) were calculated to assess relative intrarater 
and interrater reliability of the total score of SwePASS-NV. ICCs were calculated to assess 
pairwise correlation between raters (A1-B1, A1-C1, B1-C1), within the group of raters (A1-
B1-C1), and within the two ratings by the same rater (A1-A2, B1-B2, C1-C2). ICC1.1 was 
used because the raters were strategically chosen (22). In addition, ICC3.1 was used to 
examine whether systematic errors occurred. When ICC1.1 equals ICC3.1, no systematic errors 
are present (22). The ICC ranges from 0-1, where 0 indicates no agreement and 1 indicates 
perfect agreement. Reference values for ICC: .00-.25=little if any, <0.50=low, 0.50-
0.69=moderate; 0.70-0.89 high, and 0.90-1.00 very high (23). Portney and Watkins (24) 
recommend that for many clinical measurements, reliability should exceed .90 to ensure 
reasonable validity.   
Within subject standard deviation (Sw) was calculated to investigate absolute 
reliability. Sw is used to investigate how a given sum of the SwePASS-NV is related to a 'true' 
score for that person, and the variability in total scores with repeated observations, expressed 
in scores on SwePASS-NV (25). Sw was calculated using analysis of variance (ANOVA), 
where Sw equals the square root of the within-people residual mean square (25). The 
difference between a score and the true value for an individual is expected to be less than 1.96 
Sw for 95% of the observations (25). The difference between two scores for the same 
participant is expected to be <√2x1.96 Sw of the pairwise observations. This value is an 
estimate of the minimum change in scores needed to ensure that the change in scores is 
greater than the measurement error, and is referred to as the smallest detectable difference 
(SDD) (26).  
The reliability of each item of the SwePASS-NV was assessed by kappa (k) statistics. 
The reference values are: k <0.20=poor, k 0.21-0.40=weak, k 0.41-0.60=moderate, k 0.61-
0.80=high, and k 0.81-1.0=very high (27). A prerequisite for the use of k is that all scoring 
alternatives for an item are used. Percentage agreement was calculated for all items in 
addition to k. In accordance with Gjelsvik (28) and Verheyden (29) we considered 80% 
agreement as acceptable.  
The data were analysed with the 22. version of IBM SPSS for Windows (IBM SPSS, 






Translation and cross-cultural adaptation 
We chose to translate the English back-translation of the SwePASS, SwePASS-EV, into 
Norwegian, as this was the version of SwePASS approved by the original developer, Charles 
Benaim.  
During the translation process we drew attention to the fact that neither SwePASS nor 
PASS stated whether the participants should be barefoot or wear shoes during testing. The 
translation process also detected some inconsistencies between the SwePASS and their 
English back translation. The developers were kept up to date and given the opportunity to 
respond to our remarks and questions during the process to insure agreement between the 
different versions. Several new versions of SwePASS were posted online during this time 
(30). Since the changes corresponded to our desired corrections, we chose to include these in 
the final version of SwePASS-NV (appendix 1 and 2). An overview of particular challenges 
encountered during the process of translation and information on how they were approached 
can be obtained from the corresponding author. SwePASS-NV formed the basis for the next 
part of the study, examination of intra- and interrater reliability.  
Intrarater and interrater reliability study 
Characteristics of the study sample are presented in Table I. Twenty participants were 
included at the Department of Neurology and 27 participants at DPMR, HUH. Of the 47 
participants, 55% were male and 81% suffered ischemic infarction. Time between stroke 
onset and date of testing ranged between 1 and 136 days. The sample size was just short of 
the 50 recommended for reliability studies (31).  
(Insert Table I about her) 
The total scores on SwePASS-NV ranged from 3-36 (Table II) and correlated 
significantly with the participants’ group allocation based on their level of function 
(Spearman’s rho=.88, P<0.001). The relationship between group allocation and mean total 
score is illustrated in Figure 1. The distribution between the groups was somewhat skewed 
with a large proportion in group 3 ('needs only slight support with transfers', n=18) and a 
small proportion in group 1 ('no independent sitting balance', n=3). 





A large proportion of the sample (77%) received a total score on the upper half of the 
scale with 29% having a score between 31-33, and seven percent with a score between 34 and 
36.  
Relative reliability of both intrarater and interrater assessments was high (ICC ≥0.99) 
(Table III).  
(Insert Table III about here) 
Sw and SDD for intrarater and interrater reliability of the total score are reported in 
Table III. ANOVA calculation of within-subject residual mean square was 0.688 for interrater 
analyses for all raters (A1-B1-C1), and was calculated to 0.83 by use of the equation √0.688 
Sw. The difference between a participant’s total score and the 'true' measurement value was 
expected to be <1,62 points for 95% of the scores (±1,96x0.83). The SDD of the total score 
between two measurements for the same participant ranged between 1.7 and 2.7 points (95% 
CI) when scored by the different raters and 1.4-1.9 (95% CI) when scored by the same rater. k 
ranged from 0.68-1.00 (Table IV). For both intrarater and interrater assessments the items 
where k could be calculated (item 5-12) showed very high or high agreement. Percentages of 
agreement ranged from 77-100%, with item 7 showing the lowest values. Because all score 
options were not used, k could not be estimated for item 1-4. Instead, the percentage 
agreement was calculated, showing a range from 94-100%. 
(Insert Table 4 about here) 
Time between the first and second scoring (rating) was a median of 34 days (range 27-
168 days).  
Discussion 
The SwePASS-NV total score for both intrarater and interrater assessments demonstrated 
very high relative and absolute reliability. All items showed high to very high agreement.  
Translation and cross-cultural adaptation 
SwePASS was translated according to internationally recommended guidelines (20, 32). The 
back-translation was thoroughly discussed by the expert panel and corresponded well with the 
original, and was considered satisfactory. The differences primarily dealt with wording, not 
affecting content. For example, SwePASS-EV uses the wording 'without any help' while we 





slightly: While SwePASS-EV writes: 'In items 1-3, 5-6 and 10-12 the patient’s postural 
balance/control should be scored according to different degrees of support (verbal, tactile or 
supervision)' the expert panel chose the following wording: 'Items 1-3, 5-6 and 10-12 score 
the patient’s balance with respect to the degree of support/help described in the test. 
Help/support can be in form of verbal prompting, physical facilitation or supervision.' This 
change was done with the intention to make the test as unambiguous as possible to ensure that 
it is understood and used in the same way by therapists throughout Norway (cultural 
adaptation). PASS was developed in French and later translated into English. SwePASS was 
developed in Sweden, Norway's neighbouring country, with a very similar culture. We 
believe that we achieved a satisfactory translation reflecting the intentions of the developers 
of both PASS and SwePASS.  
Reliability study 
The high relative reliability (ICC≥.99) implies that most participants maintained their 
positions within their initial allocated groups with repeated measurements (33). Moreover, 
since ICC1.1 and ICC3.1 were almost identical, one can assume that no systematic errors 
influenced the calculations of relative reliability (22). These results are similar to another 
study using video to assess the reliability of the Spanish version of PASS (ICC=.99) (18) and 
similar to or higher than studies using direct scoring (interrater ICC=.97) (11). The SwePASS 
has also been found to have high reliability (16). However, because different statistical 
methods were used direct comparison of the results are impossible.  
The low Sw for all raters (range 0.7-1.0 point) indicates low measurement error of 
SwePASS-NV. A low measurement error is essential both for clinical and research purposes 
and especially for the assessment of real changes in balance over time (31). Calculations of 
SDD imply that a change in score of at least 1.9 (2) points (intrarater) and 2.7 (3) points 
(interrater) can be interpreted as a real change when two measurements of the same 
participant are compared (25). In a study by Liaw et al (12) examining patients with chronic 
stroke using PASS and direct scoring a higher SDD was found (SDD=4 points). This may be 
due to more precise wording in the scoring options in SwePASS-NV making it easier to score 
than PASS, or because the use of video is not affected by a potential difference in the 





low. The lower Sw and SDD interrater values from the second scoring indicate that experience 
with the test may further lower the measurement error.  
All individual items had high or very high k values for both intrarater and interrater 
agreement. All but one item (item 7, interrater B-C= 77%) had values above 80%. The lowest 
interrater agreement was found for items 6 (standing with support) and 7 (standing without 
support). It might be difficult to differentiate between level 2 and 3 regarding the amount of 
support needed on item 6; and for item 7 both time and degree of asymmetry must be 
considered. These differentiations may be easier to observe for the more experienced raters (A 
and B). Despite a tendency for lower k values for rater C on these items, the values are still 
high, suggesting that the reliability of SwePASS-NV may be independent of experience.  
Because all scoring alternatives were not used, k could not be estimated for items 1-4. 
We were not able to recruit more than three participants with the lowest level of function. 
Therefore, the reliability of the lower part of the scale was examined to a lesser extent than 
the other parts. It could be argued that the high agreement in our study may partly be due to 
the fact that a score of 0 (not able to perform) on items 1-3 is rare, because most patients can 
be turned on their sides by two persons. Therefore, the scoring option 0 on these items may be 
redundant. However, PASS was specifically developed to evaluate patients with poor postural 
control. Changing the scoring options could potentially lead to a higher floor effect, which 
would negate its use for these patients. Also, we found a strong relationship between levels of 
function of the participants and total score on SwePASS-NV (fig. 1).  
A floor or ceiling effect is considered to be present if 15% or more of the participants 
achieve the lowest or highest score. A floor or ceiling effect indicates low reliability and 
limits the responsiveness of the test as a change of performance in these participants cannot 
be measured (31). Seven percent of our sample received a score between 34-36, indicating no 
ceiling effect. However, with a large proportion of the sample (29%) receiving a score 
between 31-33, a higher measurement error than shown in this study could indicate a ceiling 
effect. With a median of 19 days between onset and testing and the fact that postural control is 
likely to improve during the rehabilitation process, it is also possible that SwePASS-NV may 
have a ceiling effect later on. This is in line with studies on both PASS and SwePASS 
showing that the tests are especially suited to measure change during the first three months (9, 





Strengths and limitations of the study 
The present study has several strengths, as highly standardised procedures following current 
recommendations for translation and cultural adaptation as well as recommendations with 
regard to methodological evaluation of balance measures combined with a comprehensive 
analysis of rater reliability were used (20, 26, 32, 35).  
Concerning the examination of intrarater reliability, there are no standard criteria 
regarding the time interval between assessments. We consider that the time in our study 
(median 34 days) is sufficient to minimise the influence of the raters’ memory. With direct 
scoring at an early stage there is a real probability that the patient’s performance changes 
between assessments. By using video we ensured that variability in the scoring is not a result 
of this. A reliability study allowing the use of three raters would not be possible using direct 
scoring. Due to the fact that the validity of PASS has been extensively investigated in other 
versions/languages (9, 13-15) an examination of validity was not included in this study. 
However, due to inconclusive results on the validity of SwePASS further studies may be 
called for, including a larger sample with poorer postural control (36).  
The assessment made by a therapist based on video may not be a complete reflection 
of the judgment made in live situations. We aimed to make the rating situation as similar as 
possible to direct scoring by allowing the raters to view the recording only once. Thereby, we 
ensured that agreement was not a result of watching the participants’ performance several 
times. The scorings were based on the testers’ evaluation regarding the amount of personal 
assistance/supervision needed to perform the items. Therefore, the raters were not completely 
free to make their own judgement when assigning scores. However, when using direct scoring 
in the clinic, experience with neurological patients could potentially influence the assignment 
of scores to a greater degree than in this study.  
The use of strategic sampling of participants and raters may limit the study’s external 
validity (37). On the other hand, the variety of the participants’ level of function making it 
possible to assess almost the whole range of SwePASS-NV scores and using testers and raters 
with different degrees of clinical experience with neurological patients, add to the 
generalisability of the results. Individuals with major cognitive impairments were not 






PASS and SwePASS are considered as tests of high clinical relevance. In a study from 2013 
including 77 outcome measures for stroke, PASS was selected as one of 14 measurements 
highly recommended for use in the clinic and in research (38). PASS and SwePASS include 
examination of activities that are essential to daily living, and thereby an evaluation of a wide 
spectre of activities that has been identified as important predictors for functional outcome 
(14, 39, 40). Moreover, PASS has been found to predict ambulation ability in patients with 
ischemic stroke after rehabilitation (41). Fewer changes in test positions in SwePASS make 
this test less exhausting for patients and less time consuming than PASS. SwePASS requires 
equipment available at most physiotherapy departments, it is free online and needs no 
extensive training.  
In conclusion, SwePASS-NV is a reliable balance test for adults with stroke within the 
first six months, and has no floor effect. Thereby Norwegian physiotherapists and other 
health practitioners have a new tool to assess a wide range of stroke patients and evaluate 
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Table I: Characteristics of the study sample (N=47). 
    
Variables         
Sex; n (%) 






Age in years; mean (SD) range 
 
68 (10.2) 40-86 
Diagnosis; n (%) 






Ischemic and haemorrhagic 
  
4 (8,5) 
Most affected body half; n (%) 









Days between date of ictus and date of testing: mean (SD) range (median) 25 (28.2) 1-136 (19) 
Distribution based on level of function; n (%) 
    Group 1. No independent sitting balance 
  
3 (7) 
Group 2. Can sit independently for 10 seconds 
  
8 (17) 
Group 3. Needs only slight support with transfers 
  
18 (38) 
Group 4. Safe and independent in transfers 
  
9 (19) 






Table II: Total score of the Norwegian version of SwePASS (N=47) according 
to each rater. 
Rater Mean Standard deviation Range 
A1 24.7 8.7 4-36 
A2 24.7 8.7 3-36 
B1 24.4 8.7 3-36 
B2 24.4 8.7 3-36 
C1 24.9 8.8 5-36 
C2 24.9 8.7 5-36 
A1, B1, C1 refer to the first scoring of the three raters. A2, B2, C2 refer to the second scoring 






Table III: Intrarater and interrater reliability of the total score on the Norwegian 
version of SwePASS for the participants (N=47).  
Raters 
ICC 
(1,1) 95% CI 
ICC 
(3,1) 95% CI Sw SDD 
Intrarater 
      
A1-A2 1.00 .994-.998 1.00 .994-.998 0.5 1.4 
B1-B2 .99 .989-.997 .99 .989-.997 0.7 1.9 
C1-C2 .99 .990-.997 .99 .990-.997 0.7 1.8 
Interrater 1. scoring 
     
A1-B1 .99 .988-.996 .99 .990-.997 0.7 1.9 
A1-C1 .99 .985-.995 .99 .985-.995 0.8 2.2 
B1-C1 .99 .979-.993 .99 .981-.994 1.0 2.7 
A1-B1-C1 .99 .985-.995 .99 .986-.995 0.8 2.3 
Interrater, 2. scoring  
    
A2-B2 1.00 .992-.997 1.00 .993-.998 0.6 1.6 
A2-C2 1.00 .994-.998 1.00 .994-.998 0.5 1.4 
B2-C2 .99 .990-.997 1.00 .992-.998 0.7 1.8 
A2-B2-C2 1.00 .993-.997 1.00 .994-.998 0.6 1.6 
A1, B1, C1 refer to the first scoring of the three raters. A2, B2, C2 refer to the second scoring. 
Abbreviations: ICC=intraclass correlation coefficient, CI=confidence interval, Sw=within subject 





Table IV: Intrarater and Interrater reliability of each item on SwePASS-NV for the participants (N=47) 
  1st-2nd scoring 1st scoring 
 



















1. Supine to side-lying affected side * 100 * 100 * 100 * 98 * 100 * 98 
2. Supine to side-lying unaffected side * 98 * 100 * 98 * 94 * 96 * 94 
3. Supine to sitting on the edge of the bed  * 100 * 100 * 100 * 100 * 98 * 98 
4. Sitting without support * 94 * 96 * 98 * 96 * 100 * 96 
5. Sitting to standing up .83 89 .90 94 .89 94 .97 98 .86 91 .83 89 
6. Standing with support .91 96 .95 98 .70 85 .87 94 .70 85 .73 87 
7. Standing without support  .97 98 .97 98 .88 91 .91 94 .76 83 .68 77 
8. Standing on unaffected leg .92 96 .84 91 .92 96 .88 94 .88 94 .76 87 
9. Standing on affected leg 1.00 100 .91 96 .95 98 1.00 100 .95 98 .95 98 
10. Standing picking up a shoe from the 
floor 
.87 91 .79 85 .91 94 .82 87 .81 87 .82 87 
11. Sitting down from standing up .89 94 .86 91 .89 94 .96 98 .82 89 .85 91 
12. Sitting on the edge of the bed to supine .95 98 .91 96 1.00 100 .86 94 .85 94 .90 96 
Mean .92 96 .89 95 .89 96 .91 95 .83 93 .82 91 
* Kappa could not be calculated 
             
Caption 
Figure 1: Mean total score on the Norwegian version of SwePASS for the 47 participants with regard 
to their level of function. Group 1: no independent sitting balance, group 2: can sit independently for 
10 seconds, group 3: needs only slight support with transfers, group 4: safe and independent in 
transfers, group 5: can stand on the affected leg for 10 seconds or walk without aids. 
 
 
 
 
 
